SEC Form D filing

Boston Interactome, Inc.

Biotech · Seed · Regulation D 506(b) · MA · Filed June 24, 2026

Offering amount: $1.5M
Exemption: Reg D 506(b)
Issuer state: MA
Filing date: June 24, 2026
Signature date: June 23, 2026
CIK: 0002142020

Summary

Auto-generated

Boston Interactome, Inc. name indicates biotech/life-science focus (interactome = protein interaction mapping). $1.5M offering under 506(b) anchors seed stage.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.